questionsmedicales.fr
Virus
Virus à ARN
Retroviridae
Lentivirus
Lentivirus ovins-caprins
Virus maedi-visna
Virus maedi-visna : Questions médicales fréquentes
Termes MeSH sélectionnés :
Tumor Necrosis Factor-alpha
Diagnostic
5
Virus maedi-visna
Diagnostic médical
Tests de diagnostic
Virus maedi-visna
Symptômes
Virus maedi-visna
Virus maedi-visna
Infection virale
Diagnostic précoce
Virus maedi-visna
Symptômes
5
Symptômes
Virus maedi-visna
Symptômes neurologiques
Virus maedi-visna
Portage asymptomatique
Virus maedi-visna
Évolution des symptômes
Virus maedi-visna
Prévention
5
Prévention
Virus maedi-visna
Dépistage
Virus maedi-visna
Hygiène
Virus maedi-visna
Vaccination
Virus maedi-visna
Quarantaine
Virus maedi-visna
Traitements
5
Traitement
Virus maedi-visna
Antiviraux
Virus maedi-visna
Gestion des animaux
Virus maedi-visna
Vaccins
Virus maedi-visna
Nutrition
Virus maedi-visna
Complications
5
Complications
Virus maedi-visna
Fréquence des complications
Virus maedi-visna
Production animale
Virus maedi-visna
Complications irréversibles
Virus maedi-visna
Pronostic
Virus maedi-visna
Facteurs de risque
5
Facteurs de risque
Virus maedi-visna
Races animales
Virus maedi-visna
Environnement
Virus maedi-visna
Pratiques d'élevage
Virus maedi-visna
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus maedi-visna : Questions médicales les plus fréquentes",
"headline": "Virus maedi-visna : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus maedi-visna : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-20",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus maedi-visna"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lentivirus ovins-caprins",
"url": "https://questionsmedicales.fr/mesh/D017972",
"about": {
"@type": "MedicalCondition",
"name": "Lentivirus ovins-caprins",
"code": {
"@type": "MedicalCode",
"code": "D017972",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.650.589.600"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus maedi-visna",
"alternateName": "Visna-maedi virus",
"code": {
"@type": "MedicalCode",
"code": "D014790",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xujie Duan",
"url": "https://questionsmedicales.fr/author/Xujie%20Duan",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Xiaona Shi",
"url": "https://questionsmedicales.fr/author/Xiaona%20Shi",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Shuying Liu",
"url": "https://questionsmedicales.fr/author/Shuying%20Liu",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Stefán R Jónsson",
"url": "https://questionsmedicales.fr/author/Stef%C3%A1n%20R%20J%C3%B3nsson",
"affiliation": {
"@type": "Organization",
"name": "Institute for Experimental Pathology, University of Iceland, Keldur, Reykjavik 112, Iceland."
}
},
{
"@type": "Person",
"name": "Yalçın Yaman",
"url": "https://questionsmedicales.fr/author/Yal%C3%A7%C4%B1n%20Yaman",
"affiliation": {
"@type": "Organization",
"name": "Siirt University Faculty of Veterinary Medicine, Department of Genetics, Siirt, Türkiye."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Tumor necrosis factor-alpha blockade suppresses BK polyomavirus replication.",
"datePublished": "2022-12-13",
"url": "https://questionsmedicales.fr/article/36512270",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s15010-022-01962-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders.",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37483590",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1213448"
}
},
{
"@type": "ScholarlyArticle",
"name": "Anti-tumor Necrosis Factor-Alpha Therapy and Hypoglycemia: A Real-World Pharmacovigilance Analysis.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35857191",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40264-022-01210-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease.",
"datePublished": "2023-07-05",
"url": "https://questionsmedicales.fr/article/37407724",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13679-023-00519-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of anti-tumor necrosis factor-alpha agents in treatment of sarcoidosis: A meta-analysis.",
"datePublished": "2022-12-14",
"url": "https://questionsmedicales.fr/article/36526497",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejim.2022.12.003"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Retroviridae",
"item": "https://questionsmedicales.fr/mesh/D012190"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lentivirus",
"item": "https://questionsmedicales.fr/mesh/D016086"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lentivirus ovins-caprins",
"item": "https://questionsmedicales.fr/mesh/D017972"
},
{
"@type": "ListItem",
"position": 7,
"name": "Virus maedi-visna",
"item": "https://questionsmedicales.fr/mesh/D014790"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus maedi-visna - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus maedi-visna",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus maedi-visna",
"description": "Comment diagnostiquer une infection par le virus maedi-visna ?\nQuels tests sont utilisés pour le virus maedi-visna ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer le virus chez les animaux asymptomatiques ?\nQuelle est l'importance du diagnostic précoce ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Tumor+Necrosis+Factor-alpha#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus maedi-visna",
"description": "Quels sont les symptômes principaux du virus maedi-visna ?\nLes symptômes varient-ils selon l'âge des moutons ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes sont-ils toujours présents ?\nComment évoluent les symptômes au fil du temps ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Tumor+Necrosis+Factor-alpha#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus maedi-visna",
"description": "Comment prévenir l'infection par le virus maedi-visna ?\nLes tests de dépistage sont-ils efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nLes animaux doivent-ils être vaccinés ?\nComment gérer les nouveaux animaux dans un troupeau ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Tumor+Necrosis+Factor-alpha#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus maedi-visna",
"description": "Quel est le traitement principal pour le virus maedi-visna ?\nPeut-on utiliser des antiviraux contre ce virus ?\nComment gérer les animaux infectés ?\nY a-t-il des vaccins disponibles ?\nQuel rôle joue la nutrition dans le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Tumor+Necrosis+Factor-alpha#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus maedi-visna",
"description": "Quelles complications peuvent survenir avec le virus maedi-visna ?\nLes complications sont-elles fréquentes ?\nComment les complications affectent-elles la production ?\nLes complications sont-elles réversibles ?\nQuel est le pronostic pour les animaux infectés ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Tumor+Necrosis+Factor-alpha#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus maedi-visna",
"description": "Quels sont les facteurs de risque d'infection ?\nLe stress augmente-t-il le risque d'infection ?\nLes races de moutons sont-elles affectées différemment ?\nL'environnement joue-t-il un rôle dans l'infection ?\nLes pratiques d'élevage influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Tumor+Necrosis+Factor-alpha#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le virus maedi-visna ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et des analyses PCR pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le virus maedi-visna ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et PCR sont couramment utilisés pour identifier le virus dans le sang."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques comme la pneumonie et l'encéphalite orientent le diagnostic."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer le virus chez les animaux asymptomatiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sérologiques peuvent détecter le virus même sans symptômes visibles."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du diagnostic précoce ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic précoce permet de mieux gérer la maladie et de limiter sa propagation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du virus maedi-visna ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, difficultés respiratoires et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge des moutons ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes animaux peuvent présenter des symptômes plus graves que les adultes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes neurologiques comme des tremblements et des troubles de la coordination peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains animaux peuvent être porteurs sans montrer de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Comment évoluent les symptômes au fil du temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver progressivement, menant à des complications graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus maedi-visna ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'isolement des animaux infectés et des pratiques d'élevage saines."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage régulier des troupeaux permet de détecter et d'éliminer les animaux infectés."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures d'hygiène strictes, comme le nettoyage des équipements, sont essentielles."
}
},
{
"@type": "Question",
"name": "Les animaux doivent-ils être vaccinés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien qu'il n'y ait pas de vaccin, la vaccination contre d'autres maladies est recommandée."
}
},
{
"@type": "Question",
"name": "Comment gérer les nouveaux animaux dans un troupeau ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nouveaux animaux doivent être testés et mis en quarantaine avant d'intégrer le troupeau."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour le virus maedi-visna ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique; la gestion des symptômes est essentielle."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des antiviraux contre ce virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'y a pas d'antiviraux efficaces spécifiquement pour le virus maedi-visna."
}
},
{
"@type": "Question",
"name": "Comment gérer les animaux infectés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les animaux infectés doivent être isolés et traités symptomatiquement pour améliorer leur confort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de vaccin commercialement disponible contre le virus maedi-visna."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la nutrition dans le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne nutrition peut aider à renforcer le système immunitaire des animaux infectés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le virus maedi-visna ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent pneumonie chronique et encéphalite, pouvant être mortelles."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications sont courantes chez les animaux infectés, surtout sans traitement."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la production ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la productivité des animaux, affectant la rentabilité de l'élevage."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup sont irréversibles et graves."
}
},
{
"@type": "Question",
"name": "Quel est le pronostic pour les animaux infectés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le pronostic dépend de la gravité des symptômes; beaucoup développent des complications graves."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le stress, et la densité de population dans le troupeau."
}
},
{
"@type": "Question",
"name": "Le stress augmente-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire, augmentant le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les races de moutons sont-elles affectées différemment ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines races peuvent être plus susceptibles à l'infection en raison de leur génétique."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans l'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement surpeuplé et insalubre favorise la propagation du virus."
}
},
{
"@type": "Question",
"name": "Les pratiques d'élevage influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des pratiques d'élevage inadéquates augmentent le risque de transmission du virus."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 15/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China. liushuying1968@imau.edu.cn.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
Institute for Experimental Pathology, University of Iceland, Keldur, Reykjavik 112, Iceland.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
Siirt University Faculty of Veterinary Medicine, Department of Genetics, Siirt, Türkiye.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
Ege University Faculty of Science Department of Biology Molecular Biology Section, İzmir, Türkiye; Ege University Vaccine Development Application and Research Center, İzmir, Türkiye.
Publications dans "Virus maedi-visna" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand. duncan_r_smith@hotmail.com.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Inner Mongolia Key Laboratory of Basic Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China.
Key Laboratory of Clinical Diagnosis and Treatment Technology for Animal Disease, Ministry of Agriculture, Hohhot 010018, China.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Norwegian Veterinary Institute, P.O. Box 64, 1431 Ås, Norway.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Norwegian Veterinary Institute, P.O. Box 64, 1431 Ås, Norway.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Anatomy and Physiology of Farm Animals, Department of Animal Science, Agricultural University of Athens (AUA), Iera Odos 75 str., 11855 Athens, Greece.
Publications dans "Virus maedi-visna" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Anatomy and Physiology of Farm Animals, Department of Animal Science, Agricultural University of Athens (AUA), Iera Odos 75 str., 11855 Athens, Greece.
Publications dans "Virus maedi-visna" :
BK Polyomavirus (BKPyV) infection manifests as renal inflammation and can cause kidney damage. Tumor necrosis factor-α (TNF-α) is increased in renal inflammation and injury. The aim of this study was ...
Urine specimens from 22 patients with BKPyV-associated nephropathy (BKPyVN) and 35 non-BKPyVN kidney transplant recipients were analyzed....
We demonstrated increased urinary levels of TNF-α and its receptors, TNFR1 and TNFR2, in BKPyVN patients. Treating BKPyV-infected human proximal tubular cells (HRPTECs) with TNF-α stimulated the expre...
TNF-α stimulates BKPyV replication and inhibition of its signal cascade or functionality attenuates its stimulatory effect. Our study provides a therapeutic anti-BKPyV target....
Tumor necrosis factor-alpha (TNF-α) is a pleiotropic immune cytokine that belongs to the TNF superfamily of receptor ligands. The cytokine exists as either a transmembrane or a soluble molecule, and t...
An association between tumor necrosis factor (TNF)-α inhibitors and hypoglycemia has been detected in a few case reports and small case series; however, no relevant pharmacovigilance data have been pu...
The objective of this study was to detect and characterize relevant safety signals between hypoglycemia and TNF-α inhibitor use....
Indication-focused disproportionality analysis was conducted to detect increased reporting of TNF-α-associated hypoglycemia compared with all other reports with the same indication during the same tim...
In all, 1086 adverse drug reactions related to TNF-α inhibitors were reported as 'hypoglycemia'. There were no disproportionality signals of hypoglycemia in TNF-α inhibitor users with indication of in...
Our study identified some potential pharmacovigilance signals between hypoglycemia and TNF-α inhibitors, which warrants further validation....
To summarize experimental and clinical evidence on the association between tumor necrosis factor-α (TNF-α) and nonalcoholic fatty liver disease (NAFLD) and discuss potential treatment considerations....
Experimental evidence suggests that TNF-α is a cytokine with a critical role in the pathogenesis of NAFLD. Although, the production of TNF-α may be an early event during the course of nonalcoholic fat...
Anti-tumor necrosis factor-alpha agent (anti-TNF-α) is considered an effective third-line therapy for refractory sarcoidosis,studies observing the efficacy of anti-TNF-α agents show conflicting result...
We performed an up-to-date systemic meta-analysis to determine effectiveness and further elucidate the role of anti-TNF-α in the treatment of sarcoidosis....
A systematic search was carried out in PubMed/Medline, EMBASE, and Cochrane Library for studies reporting the therapeutic effects of anti-TNF drugs on patients with pulmonary and extra-pulmonary sarco...
Clinical trials written reporting the therapeutic effects of anti-TNF drugs on patients with pulmonary and extra-pulmonary sarcoidosis were included....
Statistical analyses were performed with Comprehensive Meta-Analysis software, and the random-effects model was used. The combined overall treatment success was determined for patients with pulmonary ...
Overall treatment success rate wasdefined as no disease progression or improvement in symptoms....
Eight clinical trial articles were included in the meta-analysis; four used Infliximab, two Etanercept, one Adalimumab, and one Ustekinumab and Golimumab. The mean age of participants was 48.5 years. ...
Treatment of refractory sarcoidosis with anti-TNF-α agents was effective in both pulmonary and extrapulmonary sarcoidosis, with a slightly higher efficacy seen in extrapulmonary sarcoidosis. Further r...
At present, the occurrence and development of inflammatory diseases are closely related to the abnormal changes of the content and function of many cytokines. At the same time, targeting related cytok...
Lymphatic metastasis is a common phenomenon of cervical cancer. Tumor necrosis factor-...
In this study, cervical cancer cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with or without TNF-...
We found that TNF-...
Collectively, TNF-...
Pulmonary injury induced by mustard vesicants and radiation is characterized by DNA damage, oxidative stress, and inflammation. This is associated with increases in levels of inflammatory mediators, i...
The role of inflammatory cytokines, such as tumor necrosis-α (TNF-α) and IL-8, in gastric carcinogenesis has been investigated, but their impact remains to be further elucidated....
In this study, we measured the serum concentrations of these cytokines and H. pylori serostatus in dyspeptic patients, presenting with normal mucosa (NM = 53), chronic gastritis (CG = 94), and gastric...
Moderate levels of TNF-α were detected in the NM group (19.9 ± 19.5 pg/ml), which were nearly doubled in patients with CG (35.7 ± 28.0 pg/ml) and drastically declined in GC patients (1.8 ± 5.9 pg/ml)....
TNF-α serum concentration seemed to undergo up- and downregulation, when moving from NM to CG and from CG to GC, respectively. If confirmed in a prospective study, this cytokine can behave as a serum ...
We prepared three-dimensional (3-D) organoids of human stomach cancers and examined the correlation between the tumorigenicity and cytotoxicity of...